Trial Profile
Phase Ib Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Patients With Advanced Unresectable Soft Tissue Sarcoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Ridaforolimus (Primary) ; Docetaxel; Doxorubicin; Gemcitabine; Ifosfamide; Mesna
- Indications Soft tissue sarcoma
- Focus Adverse reactions
- 11 Jul 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 23 Feb 2011 New trial record